Search Results - "Spina, E."

Refine Results
  1. 1

    Efficacy of Antidepressants: Issues Related to Bias in Clinical Trials by Spina, E

    Published in Clinical therapeutics (01-10-2016)
    “…[...]concerns over potential adverse effects of antidepressants, including an increased risk of "suicidality" in younger populations, have continued to darken…”
    Get full text
    Journal Article
  2. 2

    The economic burden of preventable adverse drug reactions: a systematic review of observational studies by Formica, D, Sultana, J, Cutroneo, P M, Lucchesi, S, Angelica, R, Crisafulli, S, Ingrasciotta, Y, Salvo, F, Spina, E, Trifirò, G

    Published in Expert opinion on drug safety (03-07-2018)
    “…Adverse drug reactions (ADRs) are an important cause of morbidity and mortality worldwide. They are associated with healthcare costs due to hospital admissions…”
    Get more information
    Journal Article
  3. 3

    Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell lines by Gelsomino, L., Panza, S., Giordano, C., Barone, I., Gu, G., Spina, E., Catalano, S., Fuqua, S., Andò, S.

    Published in Cancer letters (01-08-2018)
    “…The detection of recurrent mutations affecting the hormone binding domain (HBD) of estrogen receptor alpha (ERα/ESR1) in endocrine therapy-resistant and…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    First-admissions in Psychiatry: a cluster analysis of a sample of inpatients from 2019 to 2021 by La Spina, E., Mastrangelo, M., Montalbani, B., Mancinelli, I., Del Casale, A., Comparelli, A., Pompili, M.

    Published in European psychiatry (01-03-2023)
    “…Introduction Only a few studies analyse the clinical and psychopathological characteristics of first-admitted inpatients regardless of diagnosis. Objectives…”
    Get full text
    Journal Article
  7. 7

    Progressive thrombosis of cervical and intracranial arteries related to Ponatinib treatment for Chronic Myeloid Leukemia by Spina, E, Renna, R, Lanterna, LA, Colleoni, ML, Andreone, V

    “…Ponatinib is a third-generation Tyrosine Kinase Inhibitor (TKI), approved as first-line treatment for Chronic Myeloid Leukaemia (CML) chronic phase. Here we…”
    Get full text
    Journal Article
  8. 8

    Antiepileptic drugs: indications other than epilepsy by Spina, Edoardo, Perugi, Giulio

    Published in Epileptic disorders (01-06-2004)
    “…Antiepileptic drugs (AEDs) are increasingly used for the treatment of several non-epileptic neurological conditions and psychiatric disorders. Most of the…”
    Get full text
    Journal Article
  9. 9
  10. 10

    CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants:a first step towards subpopulation-specific dosages by Kirchheiner, J., Brøsen, K., Dahl, M. L., Gram, L. F., Kasper, S., Roots, I., Sjöqvist, F., Spina, E., Brockmöller, J.

    Published in Acta psychiatrica Scandinavica (01-09-2001)
    “…Objective: This review aimed to provide distinct dose recommendations for antidepressants based on the genotypes of cytochrome P450 enzymes CYP2D6 and CYP2C19…”
    Get full text
    Journal Article
  11. 11

    The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: A double-blind, placebo-controlled study by Zoccali, R, Muscatello, M.R, Bruno, A, Cambria, R, Micò, U, Spina, E, Meduri, M

    Published in Schizophrenia research (01-07-2007)
    “…Abstract Based on the evidence that lamotrigine added to clozapine in refractory schizophrenic patients has reported promising results, the present 24-week…”
    Get full text
    Journal Article
  12. 12

    High-resolution profiling of linear B-cell epitopes from mucin-associated surface proteins (MASPs) of Trypanosoma cruzi during human infections by Durante, Ignacio M, La Spina, Pablo E, Carmona, Santiago J, Agüero, Fernán, Buscaglia, Carlos A

    Published in PLoS neglected tropical diseases (01-09-2017)
    “…The Trypanosoma cruzi genome bears a huge family of genes and pseudogenes coding for Mucin-Associated Surface Proteins (MASPs). MASP molecules display a…”
    Get full text
    Journal Article
  13. 13

    Salivary Gland Ultrasound in Primary Sjögren’s Syndrome: Current and Future Perspectives by Lorenzon, Michele, Spina, Erica, Franco, Francesco Tulipano Di, Giovannini, Ivan, De Vita, Salvatore, Zabotti, Alen

    “…Salivary gland ultrasound (SGUS) is the imaging modality of choice for the assessment of parotid and submandibular gland parenchyma. Being highly effective,…”
    Get full text
    Journal Article
  14. 14

    Motor performance deterioration accelerates after 50 years of age in Charcot‐Marie‐Tooth type 1A patients by Tozza, S., Bruzzese, D., Pisciotta, C., Iodice, R., Esposito, M., Dubbioso, R., Ruggiero, L., Topa, A., Spina, E., Santoro, L., Manganelli, F.

    Published in European journal of neurology (01-02-2018)
    “…Background and purpose The aim of our study was to describe, by a case‐control and cross‐sectional design, the correlation between clinical impairment and age…”
    Get full text
    Journal Article
  15. 15

    Can valproic acid be an inducer of clozapine metabolism? by Diaz, F J, Eap, C B, Ansermot, N, Crettol, S, Spina, E, de Leon, J

    Published in Pharmacopsychiatry (01-05-2014)
    “…Prior clozapine studies indicated no effects, mild inhibition or induction of valproic acid (VPA) on clozapine metabolism. The hypotheses that (i) VPA is a net…”
    Get more information
    Journal Article
  16. 16

    Pharmacokinetics of Paliperidone Palmitate in Schizophrenic Patients: Data from a Routine Therapeutic Drug Monitoring Service by Santoro, V, Bruno, A, Muscatello, M.R, D’Amico, G, Nucifora, D, Zoccali, R, Spina, E

    Published in Clinical therapeutics (01-08-2017)
    “…Methods Samples sent to the Clinical Pharmacology Unit, Messina University Hospital, for routine TDM from schizophrenic patients receiving depot injections of…”
    Get full text
    Journal Article
  17. 17

    Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005 by Savica, R., Beghi, E., Mazzaglia, G., Innocenti, F., Brignoli, O., Cricelli, C., Caputi, A. P., Musolino, R., Spina, E., Trifirò, G.

    Published in European journal of neurology (01-12-2007)
    “…To evaluate prevalence of use and prescribing patterns of antiepileptic drugs (AEDs) in Italian general practice. Primary care data were obtained from the…”
    Get full text
    Journal Article
  18. 18

    EKG Parameters in Children and Adolescents Treated with Second-Generation Antipsychotics: A 24-Months Prospective Follow-Up Study by Lamberti, M, Gagliano, A, Italiano, D, Morello, A, Guerriero, L, D’Amico, G, Germanò, E, Calabrò, M, Persico, A, Spina, E

    Published in Clinical therapeutics (01-08-2017)
    “…Background Second-generation antipsychotics (APs) are increasingly prescribed in pediatric patients for the treatment of a number of psychiatric disorders…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables by Diaz, F J, Santoro, V, Spina, E, Cogollo, M, Rivera, T E, Botts, S, de Leon, J

    Published in Pharmacopsychiatry (01-05-2008)
    “…The purpose of this study was to estimate the effect sizes of drug interactions on plasma clozapine concentrations, adjusting for potentially confounding…”
    Get more information
    Journal Article